Clinical trials: Aspirin Resistance, open to volunteers
Preeclampsia, Preeclampsia (PE)
Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
This study's primary purpose is to determine the relationship between aspirin metabolism and markers of metabolic dysfunction among patients at risk for preeclampsia.
- Conditions
- Preeclampsia, Preeclampsia (PE), Preeclampsia (PE) Risk, Obesity and Obesity-related Medical Conditions
- Trial name
- RAMP (NCT06802861)
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- University of Tennessee Graduate School of Medicine
Prostate Cancer
Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
This is a 2x2 factorial randomized, multicenter, international, open phase III trial. The primary objective is to evaluate the benefit of acetylsalicylic acid and atorvastatin on overall survival (OS) (main endpoint) for patients…
- Trial name
- PEACE-4 (NCT03819101)
- Testing
- Acetylsalicylic acid, Atorvastatin
- Where
- 30 sites in Czechia, France and 4 more
- Volunteers
- 1,210 people
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
Myeloproliferative Neoplasms (MPN)
Long-term Efficacy of Once Daily Versus Twice Daily Aspirin in High-risk MPN Patients With Aspirin Resistance
Patients with myeloproliferative neoplasm (MPN) could have laboratory aspirin resistance and then increasing dose of aspirin from once daily to twice daily regimen is suggested.
- Trial name
- NCT06740916
- Testing
- 81-mg aspirin once daily, 81-mg aspirin twice daily
- Where
- Thailand
- Volunteers
- 240 people
- Sponsor
- Siriraj Hospital